Medpharm: 3M bows out, sticks to core business

Adjust font size:

Increase font size Decrease font size

Medpharm: 3M bows out, sticks to core business

3M will divide its puzzling pharmaceutical side venture three ways among four buyers, for a total sale of $2.1 billion.

Graceway Pharmaceuticals of Tennessee will buy about 40 percent, being 3M's pharmaceutical operations in the US, Canada and Latin America.

Media AB of Stockholm, Sweden, will pay $857 million for its share, and two private equity firms will buy the remainder for the AsiaPac operations.

Comments on this story

no comments yet...

click here to add a comment

You must be registered & logged in to add comments
Please register

already have an account and just want to login?

email address
password
remember me
 

Highlights

Leadership and StrategyDesign and InnovationWorld class manufacturingSkills and productivityIT in manufacturingLogistics and supply chainOperations and maintenanceEnergy business

Related Content

Boeing Celebrates the Premiere of the 787 Dreamliner
EVERETT, Wash., July 08, 2007 -- Today, Boeing...
more…